UMPS and cancer: De novo pyrimidine biosynthesis involves cytosolic carbamoyl-phosphate synthetase II, aspartate transcarbamylase, and dihydroorotase, uridine monophosphate synthetase (UMPS), and DHODH, contributing to ferroptosis resistance in cancer cells (e.g., HeLa cells) and in xenograft models [196].